Skip to main content
. 2021 Jan 14;13(2):286. doi: 10.3390/cancers13020286

Figure 1.

Figure 1

Association of type of progressive disease (hyperprogression (HPD) vs. non-HPD) with progression free survival (PFS) post immunotherapy initiation (ICI).